Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry refers to a **non-specific balanced multi-electrolyte solution concept** composed of potassium chloride, sodium acetate, sodium chloride, magnesium chloride, and sodium, used as a source of water and electrolytes and as an alkalinizing agent. Public sources support closely related marketed products such as **Multiple Electrolytes Injection, Type 1, USP**, **PLASMA-LYTE A**, and **Physiolyte**, but those exact products also contain **sodium gluconate** and differ by presentation, pH, and intended use. Accordingly, the queried name is best treated as a combination electrolyte formulation descriptor rather than a uniquely identifiable single branded asset. Pharmacologically, these solutions restore extracellular fluid volume and plasma electrolyte composition, while acetate acts as a bicarbonate precursor that contributes an alkalinizing effect; they are used intravenously for hydration/electrolyte replacement or, in irrigating formulations, for general irrigation, washing, and rinsing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium acetate + sodium chloride + magnesium chloride + sodium.